Renovos is backed by years of academic research and deep understanding of the regenerative medicine field. Renovos offers a portfolio of products to meet the needs of the regenerative medicine industry.
Renovos is addressing the unmet clinical needs within the orthopaedic space by developing a proprietary platform technology based on nanoclay gels. These nanoclay gels act as injectable scaffolds which attract cells and localise and retain delivered biologics for safer and more efficient regenerative medicine applications.
We also support scientists with novel research solutions. Our commercial proposition includes primary mesenchymal stem cells for research, sourced from orthopaedic patient cohorts. We also offer research services for screening and testing of novel biomaterials and compounds for biocompatibility, toxicology, angiogenesis and bone / cartilage regeneration.